Perspectives of the treatment of rheumatic diseases in the beginning of the XXi century
Nosonov, E.L.
Terapevticheskii Arkhiv 83(5): 5-9
2011
ISSN/ISBN: 0040-3660 PMID: 21780649 Document Number: 652286
Prevalence of immunoinflammatory diseases in general population is about 10%. Rheumatic diseases, first of all rheumatoid arthritis (RA), are among most prevalent immunoinflammatory diseases. In the first decade of the XXI century great progress was achieved in definition of the mechanisms of RA onset and in development of new approaches to its treatment. The article provides information about novel drugs which are effectively used not only in RA but also in other imunoinflammatory diseases.